Cristin Wagner helps innovative companies protect and develop their intellectual property portfolios. She takes the time to understand her clients’ needs and align legal strategies with their goals to achieve optimal results. She is regarded for her practical approach and expertise in the areas of patent litigation and patent portfolio management.
Throughout her career, Cristin has handled complex litigation matters for a broad client base ranging from leading pharmaceutical companies to individual inventors. She has experience with cross-border enforcement of intellectual property rights and, in particular, developing worldwide enforcement strategies. In addition to her litigation practice, Cristin provides advice and conducts due diligence for patent acquisitions and negotiates and drafts patent licenses.
Prior to joining Schwabe, Cristin was in-house counsel at a publicly held patent licensing company, where she managed worldwide licensing and enforcement programs. Her first-hand experience finding cost-efficient representation helps her develop efficient strategies and budgeting for litigation matters.
Cristin spent the first part of her career as a patent litigator with a large international law firm in Canada. There she managed all phases of complex multimillion-dollar pharmaceutical patent infringement cases and applications under the Patented Medicines (Notice of Compliance) Regulations. This experience provided her with a thorough understanding of the various regulatory and business issues facing the pharmaceutical industry, including generic competition and the importance of patent and regulatory exclusivities for innovative drug products.
Admitted to practice only in California, the Law Society of Upper Canada, and the USPTO. Supervised by shareholders in the Portland office.
- Achieved a $22.1 million verdict for past damages after jurors found willful infringement.
- Achieved a $9.2 million verdict for past damages (future damages still being determined) after jurors found willful infringement.
- Served as co-counsel on an appeal from the Federal Court of Appeal in an application under the Patented Medicines (Notice of Compliance) Regulations involving protecting a client’s multimillion-dollar market for the blockbuster medicine Plavix®.
- Served as lead negotiator on several patent licensing agreements resulting in significant revenue for a publicly traded company.
Memberships & Awards
- American Intellectual Property Law Association
- Women in Technology International
Resources & Ideas
Seminars & Speaking Engagements
- May 2, 2018
- June 11, 2018
- June 4, 2018
- May 29, 2018
- May 21, 2018
- May 7, 2018
- April 23, 2018
- April 2, 2018
- March 26, 2018
- March 19, 2018
- March 5, 2018
- February 12, 2018
- January 8, 2018
- Schulich School of Law, Dalhousie UniversityJuris Doctor (2000)
- University of Saskatchewan, CanadaBachelor of Science, Biochemistry (1997)
California State Courts
Law Society of Ontario
United States Patent and Trademark Office